Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Contrast Media × Dermatologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 6 Thoracic 5 Genitourinary 4 Gastrointestinal 4 Head & Neck 3 Sarcoma 2 Gynecologic 2 Breast 2 Plasma cell 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Endocrine 1 Dermatologic 1

Conditions

Melanoma 1 Lung Neoplasms 1

Interventions

pembrolizumab 324 Nivolumab 289 Ipilimumab 260 Cyclophosphamide 193 aldesleukin 145 Interleukin-2 109 fludarabine phosphate 106 Temozolomide 83 Dacarbazine 81 fludarabine 80 Radiotherapy 74 trametinib 73 Vemurafenib 69 dabrafenib 66 Biopsy 65 sargramostim 50 Bevacizumab 50 Radiosurgery 49 Paclitaxel 49 Peripheral Blood Stem Cell Transplantation 48 Carboplatin 48 Imiquimod 47 Aminolevulinic Acid 47 Magnetic Resonance Spectroscopy 46 binimetinib 45 Cisplatin 45 CTLA-4 Antigen 43 cemiplimab 42 atezolizumab 41 3-ingenyl angelate 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡